Burden of pulmonary arterial hypertension in Germany

Respiratory Medicine

Volumn 104, Issue 6, 2010, Pages 902-910

  Wilkens, H ^a   Grimminger, F ^b   Hoeper, M ^c   Stahler G ^d   Ehlken, B ^e   Plesnila Frank, C ^e   Berger, K ^e   Resch, A ^f   Ghofrani, A ^b  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL GIESSEN   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d Lungenfachklinik Löwenstein ^*  (Germany)

^e IQVIA   (United States)

^f PFIZER INC   (United States)

Author keywords

Costs; Health care provision; Pulmonary arterial hypertension; Quality of life; Resource consumption; Treatment patterns

Indexed keywords

ENDOTHELIN RECEPTOR ANTAGONIST; PHOSPHODIESTERASE V INHIBITOR; PROSTACYCLIN DERIVATIVE; PHOSPHODIESTERASE INHIBITOR;

ADULT; AGED; ARTICLE; COST BENEFIT ANALYSIS; COST OF ILLNESS; DRUG COST; FEMALE; GERMANY; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH ECONOMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBLIC HEALTH PROBLEM; PULMONARY HYPERTENSION; QUALITY OF LIFE; RETROSPECTIVE STUDY; SYMPTOM; ECONOMICS; EVALUATION STUDY; HYPERTENSION, PULMONARY; MIDDLE AGED; VALIDATION STUDY;

ADULT; AGED; COST-BENEFIT ANALYSIS; FEMALE; GERMANY; HEALTH EXPENDITURES; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PHOSPHODIESTERASE INHIBITORS; RETROSPECTIVE STUDIES;

EID: 77952419236     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2010.01.002     Document Type: Article

References (31)

1. Badesch D.B., Abman S.H., Simonneau G., Rubin L.J., and McLaughlin V.V. Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines. Chest 131 6 (2007 Jun) 1917-1928
2. Rich S. The current treatment of pulmonary arterial hypertension: time to redefine success. Chest 130 4 (2006 Oct) 1198-1202
3. Cenedese E., Speich R., Dorschner L., Ulrich S., Maggiorini M., Jenni R., et al. Measurement of quality of life in pulmonary hypertension and its significance. Eur Respir J 28 (2006 May 2) 808-815
4. Shafazand S., Goldstein M.K., Doyle R.L., Hlatky M.A., and Gould M.K. Health-related quality of life in patients with pulmonary arterial hypertension. Chest 126 5 (2004 Nov) 1452-1459
5. Taichman D.B., Shin J., Hud L., Archer-Chicko C., Kaplan S., Sager J.S., et al. Health-related quality of life in patients with pulmonary arterial hypertension. Respir Res 6 (2005) 92
6. Zlupko M., Harhay M.O., Gallop R., Shin J., Archer-Chicko C., Patel R., et al. Evaluation of disease-specific health-related quality of life in patients with pulmonary arterial hypertension. Respir Med 102 10 (2008 Oct) 1431-1438
7. Löwe B., Grafe K., Ufer C., Kroenke K., Grünig E., Herzog W., et al. Anxiety and depression in patients with pulmonary hypertension. Psychosom Med 66 6 (2004 Nov) 831-836
8. White J., Hopkins R.O., Glissmeyer E.W., Kitterman N., and Elliott C.G. Cognitive, emotional, and quality of life outcomes in patients with pulmonary arterial hypertension. Respir Res 7 (2006) 55
9. Simonneau G., Galie N., Rubin L.J., Langleben D., Seeger W., Domenighetti G., et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 43 12 Suppl. S (2004 Jun 16) 5S-12S
10. McLaughlin V.V., Archer S.L., Badesch D.B., Barst R.J., Farber H.W., Lindner J.R., et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation 119 16 (2009 Apr 28) 2250-2294
11. Farber H.W., and Loscalzo J. Pulmonary arterial hypertension. N Engl J Med 351 16 (2004 Oct 14) 1655-1665
12. Humbert M., Sitbon O., Chaouat A., Bertocchi M., Habib G., Gressin V., et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med 173 9 (2006 May 1) 1023-1030
13. Peacock A.J., Murphy N.F., McMurray J.J., Caballero L., and Stewart S. An epidemiological study of pulmonary arterial hypertension. Eur Respir J 30 1 (2007 Jul) 104-109
14. Benedict N., Seybert A., and Mathier M.A. Evidence-based pharmacologic management of pulmonary arterial hypertension. Clin Ther 29 10 (2007 Oct) 2134-2153
15. Galie N., Manes A., Negro L., Palazzini M., Bacchi-Reggiani M.L., and Branzi A. A meta-analysis of randomized controlled trials in pulmonary arterial hypertension. Eur Heart J 30 4 (2009 Feb) 394-403
16. Hoeper M.M., Markevych I., Spiekerkoetter E., Welte T., and Niedermeyer J. Goal-oriented treatment and combination therapy for pulmonary arterial hypertension. Eur Respir J 26 5 (2005 Nov) 858-863
17. EuroQol Group. EuroQol- a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy 16 3 (1990 Dec) 199-208
18. Ware J., Snow K., Kosinski M., and Gandek B. SF-36 health survey: manual and interpretation guide (2003), The Health Institute, New England Medical Centre, Boston
19. Löwe B., Spitzer R., and Zipfel A. PHQ-D - Gesundheitsfragebogen für Patienten. Manual Komplettversion und Kurzform (2002) Heidelberg
20. Rote Liste®. Rote Liste 2007 (2007), Editio Cantor Verlag, Frankfurt/Main
21. Schwabe U., and Paffrath D.H. Arzneimittelverordnungsreport 2006 (2007), Springer Verlag, Berlin, Heidelberg
22. EBM 2000 Plus - Einheitlicher Bewertungsmaßstab. 1. Quartal 2007 (2006) Berlin
23. Übersicht Landesbasisfallwerte 2006. http://www.aok-gesundheitspartnerde/bundesverband/krankenhaus/budgetverh andlung/landesbasisfallwert/2006 2006 August 14 [cited 2006 Sep 19].
24. G-DRG-Fallpauschalen-Katalog (Jan 1 2007), Institut für das Entgeldsystem im Krankenhaus (InEK gGmbH)
25. Greiner W., and Uber A. Gesundheitsökonomische Studien und der Einsatz von Lebensqualitätsindices am Beispiel des LQ- Indexes EQ-5D (EuroQol). In: Ravens- Sieberer U., and Cieza A. (Eds). Lebensqualität und Gesundheitsökonomie in der Medizin ecomed Verlagsgesellschaft (2000) 336-351 Landsberg
26. McNemar Q. Note on the sampling error of the difference between correlated proportions or percentages. Psychometrika 12 (1947) 153-157
27. Ellert U., and Bellach B.M. The SF-36 in the Federal Health Survey-description of a current normal sample. Gesundheitswesen 61 Spec No (1999 Dec) S184-S190
28. Fischler M., Speich R., Dorschner L., Nicod L., Domenighetti G., Tamm M., et al. Pulmonary hypertension in Switzerland: treatment and clinical course. Swiss Med Wkly 138 25-26 (2008 Jun 28) 371-378
29. Highland K.B., Strange C., Mazur J., and Simpson K.N. Treatment of pulmonary arterial hypertension: a preliminary decision analysis. Chest 124 6 (2003 Dec) 2087-2092
30. Chen H., Taichman D.B., and Doyle R.L. Health-related quality of life and patient-reported outcomes in pulmonary arterial hypertension. Proc Am Thorac Soc 5 (2008 Apr 22) 623-630
31. Meads D.M., McKenna S.P., Doughty N.J., Doward L.C., and Pepke-Zaba J. Validation of the cambridge pulmonary hypertension outcome review (CAMPHOR). Value in Health 7 6 (2004 Nov/Dec) 700